Carroll Financial Associates’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Carroll Financial Associates’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	-$3K	–	1816
2021 Q1	$3K	Hold	50	–	–	﹤0.01%	1460
2020 Q4	$3K	Hold	50	–	–	﹤0.01%	1350
2020 Q3	$3K	Hold	50	–	–	﹤0.01%	1289
2020 Q2	$3K	Hold	50	–	–	﹤0.01%	1304
2020 Q1	$2K	Hold	50	–	–	﹤0.01%	1313
2019 Q4	$3K	Sell	50 -54	-52%	-$3.29K	﹤0.01%	1331
2019 Q3	$5K	Hold	104	–	–	﹤0.01%	1197
2019 Q2	$6K	Buy	104 +54	+108%	+$3.31K	﹤0.01%	1161
2019 Q1	$3K	Hold	50	–	–	﹤0.01%	1213
2018 Q4	$3K	Hold	50	–	–	﹤0.01%	1140
2018 Q3	$3K	Hold	50	–	–	﹤0.01%	1165
2018 Q2	$3K	Hold	50	–	–	﹤0.01%	1136
2018 Q1	$3K	Hold	50	–	–	﹤0.01%	1120
2017 Q4	$3K	Hold	50	–	–	﹤0.01%	1096
2017 Q3	$3K	Hold	50	–	–	﹤0.01%	1076
2017 Q2	$3K	Hold	50	–	–	﹤0.01%	1068
2017 Q1	$2K	Hold	50	–	–	﹤0.01%	1101
2016 Q4	$2K	Buy	+50	New	+$2.88K	﹤0.01%	1057

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Carroll Financial Associates's PJP Position: Q2 2021 in Review

Carroll Financial Associates sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2021, closing a stake of 50 shares — an estimated $3K sold.

Carroll Financial Associates first reported a position in PJP in Q4 2016 and held it in 18 quarters. The position peaked at $6K in Q2 2019. 90 funds tracked by Wall St. Rank hold PJP as of Q2 2021.

Carroll Financial Associates reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
Carroll Financial Associates sold 50 Invesco Pharmaceuticals ETF shares in Q2 2021, an estimated $3K.
Carroll Financial Associates first reported a position in Invesco Pharmaceuticals ETF in Q4 2016 and held it in 18 quarters.
Carroll Financial Associates's Invesco Pharmaceuticals ETF position peaked at $6K in Q2 2019.
90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2021.

Based on Carroll Financial Associates's 13F filing for Q2 2021, filed 13 Jul 2021.